Porton to Showcase Cutting-edge Innovations at BIO-Europe Spring 2025

Porton Pharma Solutions will once again participate in BIO-Europe Spring 2025, held from March 17th to 19th, at booth #87. This prestigious event is anticipated to gather over 3,700 scientific leaders and industry pioneers, fostering new strategic collaborations.

As a globally leading end-to-end CDMO enterprise, Porton Pharma Solutions stands at the forefront of the industry with its cutting-edge technology platforms and extensive project delivery experience. We excel in various fields, including small molecules, peptides and oligonucleotides, antibody-drug conjugates (ADCs) - encompassing antibodies, payload-linkers, conjugation, and formulation filling - as well as Advanced Therapy Medicinal Products (ATMPs).

At this conference, Porton will showcase its latest innovative solutions, aiming to provide you with flexible and diverse collaboration options that cater to your customized needs while driving continuous progress in the biopharmaceutical industry.

We cordially invite you to visit our booth #87 to discuss potential collaboration opportunities.

To ensure a more professional meeting experience for you, we have specially opened a booking channel. To schedule an onsite meeting, please visit our official website's offline meeting page, or directly email us at business@portonpharma.com. Our dedicated team will be more than happy to arrange your meeting and ensure your participation is both efficient and enjoyable.

Join us in exploring the future of pharmaceutical innovation at BIO-Europe Spring 2025!